1 / 7

Coronary Stents Market Share, Trends, Analysis and Forecast 2032

The Coronary Stents Market study focuses major leading industry players with information such as company profiles, product picture and specification, capacity, production, price, cost, revenue and contact information. It provides information on trends and developments, and focuses on markets and materials, capacities and technologies, and on the changing structure.

energy010
Download Presentation

Coronary Stents Market Share, Trends, Analysis and Forecast 2032

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Coronary Stents Market with Report In Depth Industry Analysis on Trends, Growth, Opportunities and Forecast till 2032

  2. Industry Insights • Coronary Stents Market size will depict a noticeable growth during 2023-2032, owing to rising demand for minimally invasive procedures. There has been a rising inclination towards minimally invasive surgeries owing to the constant technological innovations in cardiac surgical procedures. • A coronary stent is used to treat blocked or restricted coronary arteries. It is also used to enhance blood flow right after a heart attack. • Currently, all angioplasty operations use coronary stents. As per credible reports, more than 2 million people get stent every year. • The key players operating in the coronary stents market are also focusing on developing various minimally invasive coronary stents to satisfy the rising patient needs, thus fostering the market expansion.

  3. To cite an instance, in 2023, Abbott announced entering into a definitive agreement to acquire CSI. CSI develops and commercializes products for treating peripheral and coronary vascular disease. • The latest acquisition will enable Abbott to add innovative, complementary technologies to its leading vascular device offerings. • Based on the product, the bare metal stent segment is anticipated to register sturdy growth through 2032. The segmental growth can be credited to the growing licensed use of the bare-metal stent in cardiac arteries. • Besides, these stents also reduce the risk of stent thrombosis and abrupt vessel closure, lowering the target lesion revascularization rate. Various studies involving bare stents are underway. In 2023, recent research revealed that the combination of double bare stent and endobiliary radiofrequency ablation could support ingrowth reduction.

  4. Regional Analysis • In terms of the regional context, the North America coronary stents market held over 25.5% of the market in 2022 and is expected to register notable gains through 2032. The regional market growth will come from the rising strategic initiatives by leading industry players including the launch of next-generation coronary stents to cater to the rising patient demand. • Competitive Analysis • B. Braun Melsungen AG • Terumo Corporation Biosensors International Group • Biotronik SE & Co. KG • Elixir Medical Corporation • Boston Scientific Corporation • Abbott Laboratories

  5. Coronary Stents Market @ https://www.gminsights.com/industry-analysis/coronary-stents-market Request for sample of this research report @ https://www.gminsights.com/request-sample/detail/2966 Request for customization @ https://www.gminsights.com/roc/2966

  6. Stay In Touch Social Media:

  7. THANK YOU www.gminsights.com

More Related